Search

everythinglearnresearchcommunity

for

Search:↓

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Minoxidil can reduce functions related to androgen receptors.

These medications for BPH have known risks and may have new side effects.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

AS101 reduces hair loss from chemotherapy.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

These medications for BPH have known risks and may have new side effects.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

PPARα agonists may help treat alopecia areata by reducing inflammation.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.